V

Ventus Therapeutics

80 employees

Ventus Therapeutics develops small molecule drugs that target autoimmune diseases, inflammatory diseases, and cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Therapeutics
Health Care

Date founded

2019

Funding rounds raised

Total raised

$140M

from 14 investors over 14 rounds

V

Ventus Therapeutics raised $70M on September 29, 2022

Investors: Novo Nordisk Ltd

V

Ventus Therapeutics raised $140M on February 9, 2022

Investors: Qatar Investment Authority, GV, Versant Ventures, RA Capital Management, L.P., Andreessen Horowitz, Casdin Capital, LLC and SoftBank Investment Advisers

V

Ventus Therapeutics raised $100M on April 8, 2021

Investors: Casdin Capital, LLC, Versant Ventures, RA Capital Management, L.P. and GV

V

Ventus Therapeutics raised $60M on May 6, 2020

Investors: Versant Ventures and GV

FAQ